In an article in Health Economics, Prof Devlin and her co-authors demonstrate the promise of using Lead Time TTO to value health 'state worse than death'. They demonstrate the potential advantages of the approach and identify important next steps in developing the methodology.
The 13 April OHE Lunchtime Seminar with Prof William Comanor was attended by about 40 people, hailing from academia, the pharmaceutical and biotechnology industries, consultancies, physicians’ associations, and government.
The OHE has won a £325,000 grant from the UK Department of Health that focuses on developing a new health status index – the 5 level EQ-5D --that will capture smaller changes in health related quality of life.
In a recent OHE Briefing, five leading European experts in health economics provide a comprehensive international review of changes in health economic evaluation and the reasons for them. The authors express concern that the basis for health care decision making today has evolved away from the societal perspective of cost benefit analysis to the payer perspective of cost-effectiveness analysis.